Table 2. Multivariate analysis for OS at... | American Society of Hematology

Table 2.

Multivariate analysis for OS at 3 years after alloHCT

Variable	HR	95% Confidence interval	P
Cytogenetic response
CK at diagnosis, but not pre-alloHCT (vs no CK)	0.87	0.35-2.15	.76
CK pre-alloHCT (vs no CK)	1.31	0.52-3.35	.57
Pre-alloHCT BM blasts ≥5% (vs <5% blasts)	1.64	0.8-3.36	.18
Melphalan-based conditioning (vs no melphalan)	0.71	0.43-1.17	.17
Meets ICC definition of TP53^mut MN (vs not)	2.62	1.18-5.83	.019

Variable	HR	95% Confidence interval	P
Cytogenetic response
CK at diagnosis, but not pre-alloHCT (vs no CK)	0.87	0.35-2.15	.76
CK pre-alloHCT (vs no CK)	1.31	0.52-3.35	.57
Pre-alloHCT BM blasts ≥5% (vs <5% blasts)	1.64	0.8-3.36	.18
Melphalan-based conditioning (vs no melphalan)	0.71	0.43-1.17	.17
Meets ICC definition of TP53^mut MN (vs not)	2.62	1.18-5.83	.019

Boldface values indicate statistically significant at P < 0.05.